Clinical evidence for osteoarthritis as an inflammatory disease

被引：27
|
作者：
Pincus T. [1 ]
机构：
[1] Division of Rheumatology, Vanderbilt University Medical Center, 203 Oxford House, Box 5, Nashville, 37232-4500, TN
来源：
Current Rheumatology Reports | 2001年 / 3卷 / 6期
关键词：
Acetaminophen; Etodolac; Misoprostol; Nabu; Nabumetone;
D O I：
10.1007/s11926-001-0068-4
中图分类号：
学科分类号：
摘要：
Osteoarthritis (OA) is not a simple consequence of “wear and tear” or aging—the presence of cytokines suggests a role for inflammation. OA is polyarticular in most patients, with metabolic and differential risk factors for prevalence and severity. Odds ratios for the prevalence of OA according to formal education levels are similar to those seen for dysregulatory diseases such as hypertension, diabetes, and rheumatoid arthritis. Clinical survey data indicate significant patient preference for nonsteroidal anti-inflammatory drugs (NSAIDs) compared with acetaminophen. A recent crossover clinical trial indicated significantly greater efficacy of the NSAID, diclofenac/misoprostol, versus acetaminophen for most patients with OA. © 2001, Current Science Inc.
引用
收藏
页码：524 / 534
页数：10
相关论文
共 50 条
  • [21] Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence
    Bilski, Jan
    Mazur-Bialy, Agnieszka
    Brzozowski, Bartosz
    Magierowski, Marcin
    Zahradnik-Bilska, Janina
    Wojcik, Dagmara
    Magierowska, Katarzyna
    Kwiecien, Slawomir
    Mach, Tomasz
    Brzozowski, Tomasz
    PHARMACOLOGICAL REPORTS, 2016, 68 (04) : 827 - 836
  • [22] Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
    Nakase, Hiroshi
    Uchino, Motoi
    Shinzaki, Shinichiro
    Matsuura, Minoru
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Saruta, Masayuki
    Hirai, Fumihito
    Hata, Keisuke
    Hiraoka, Sakiko
    Esaki, Motohiro
    Sugimoto, Ken
    Fuji, Toshimitsu
    Watanabe, Kenji
    Nakamura, Shiro
    Inoue, Nagamu
    Itoh, Toshiyuki
    Naganuma, Makoto
    Hisamatsu, Tadakazu
    Watanabe, Mamoru
    Miwa, Hiroto
    Enomoto, Nobuyuki
    Shimosegawa, Tooru
    Koike, Kazuhiko
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (06) : 489 - 526
  • [23] Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations
    Becker, Heike E. F.
    Penders, John
    Jonkers, Daisy M. A. E.
    GASTROENTEROLOGY, 2022, 162 (01) : 4 - 8
  • [24] The role of stress in the development and clinical course of inflammatory bowel disease: Epidemiological evidence
    Maunder, Robert G.
    Levenstein, Susan
    CURRENT MOLECULAR MEDICINE, 2008, 8 (04) : 247 - 252
  • [25] Innate immunity and inflammatory bowel disease: A review of clinical evidence and future application
    Katakura K.
    Watanabe H.
    Ohira H.
    Clinical Journal of Gastroenterology, 2013, 6 (6) : 415 - 419
  • [26] Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease
    Boisse, Lysa
    Chisholm, Susan P.
    Lukewich, Mark K.
    Lomax, Alan E.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (10): : 1026 - 1033
  • [27] EVIDENCE OF ACROLEIN AS AN INFLAMMATORY BIOMARKER IN SYNOVIAL FLUID OF DOGS WITH OSTEOARTHRITIS
    Herr, S.
    Malek, S.
    Rochat, M. C.
    Moore, G. E.
    Ko, J. C.
    Shi, R.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 : S161 - S162
  • [28] Yet more evidence that osteoarthritis is not a cartilage disease
    Brandt, K. D.
    Radin, E. L.
    Dieppe, P. A.
    van de Putte, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (10) : 1261 - 1264
  • [29] Clinical Evidence for the Microbiome in Inflammatory Diseases
    Slingerland, Ann E.
    Schwabkey, Zaker
    Wiesnoski, Diana H.
    Jenq, Robert R.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [30] Is inflammatory signaling involved in disease -related muscle wasting? Evidence from osteoarthritis, chronic obstructive pulmonary disease and type II diabetes
    Dalle, Sebastiaan
    Koppo, Katrien
    EXPERIMENTAL GERONTOLOGY, 2020, 137
12345